Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Metadata
Title
Evaluation of dysthymic disorder with technetium-99 m hexamethylpropylene amine oxime brain single-photon emission tomography
Authors
Ali Sarikaya
Engin Karaşin
Tevfik Fikret Çermik
Ercan Abay
Şakir Berkarda
Publication date
01-03-1999
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/1999
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s002590050386

Other articles of this Issue 3/1999

European Journal of Nuclear Medicine and Molecular Imaging 3/1999 Go to the issue

Original article

Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer

Occasional survey

Radionuclide therapy practice and facilities in Europe

Original article

Positron emission tomography of murine liver metastases and the effects of treatment by combretastatin A-4

Original article

Three-dimensional contour detection of left ventricular myocardium using elastic surfaces

Short communication

A deconvolution technique for processing small intestinal transit data

Original article

Quantification of cerebral blood flow using technetium-99m ethyl cysteinate dimer and single-photon emission tomography